Cannara Biotech (CNSX:LOVE – Get Free Report) Director Donald John Olds bought 25,000 shares of Cannara Biotech stock in a transaction on Tuesday, December 10th. The shares were purchased at an average cost of $0.78 per share, for a total transaction of $19,400.00.
Cannara Biotech Price Performance
Cannara Biotech Company Profile
Cannara Biotech Inc is a vertically integrated cannabis company building the largest indoor cannabis cultivation facility in Quebec, a modern and secure 625,000 square foot facility. Leveraging Quebec’s low electricity costs, Cannara will produce high-grade indoor cannabis, specializing in derivative products and brands.
Featured Stories
- Five stocks we like better than Cannara Biotech
- How to Use the MarketBeat Stock Screener
- The Great CPU Race: AMD and Intel Battle for Dominance
- Dividend Payout Ratio Calculator
- GameStop Turns a Profit: So What? It’s Still Not Worth Investing
- 3 Tickers Leading a Meme Stock Revival
- C3.ai Stock Surges on Strong Sales Despite Profit Concerns
Receive News & Ratings for Cannara Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cannara Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
